Loading...
Thumbnail Image
Item

Rapid versus Standard Infliximab and Infliximab Biosimilar Infusions in Pediatric Inflammatory Bowel Disease (IBD): Comparison of Adverse Reactions

Authors
Zuzarte, Catherine
Aktay, Atiye
Advisor
Date
2024-12-09
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Poster/Presentation
Research Area
Jurisdiction
Other Titles
See at
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Advances in Inflammatory Bowel Diseases (AIBD). December 09, 2024.
Series/Report No.
Sponsors
Rights/Terms
Attribution-NonCommercial-NoDerivatives 4.0 International
Citation
Identifier to cite or link to this item
Scopus Identifier
Embedded videos